Announced Mon, 10 Aug, 2026 · 15:40 IST
Q1 results approved; CFO resigns, new CFO appointed
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reactionminutes from the announcement price · days from the prior close
—Next day
₹3.82
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.2%—
Pharmaceuticals peers, median of 165sector-0.4%—
Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
—-0.2—+0.1—
Next day
—+0.2—-0.4—
2d
—+0.4—+0.1—
3d
-5.0+0.4-5.4-0.4-4.5
4d
-9.7+0.6-10.2-0.9-8.8
5d
-9.7+0.9-10.6-0.5-9.2
1w
-5.2+0.9-6.1-1.0-4.3
15d
-9.9+0.9-10.9-0.6-9.4
1m
-1.8+2.3-4.2+1.1-3.0
2m
—-1.1—-3.1—
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending
Minute windows have no benchmark: there is no intraday index history to compare against.
AI summary
Board approved Q1FY27 unaudited results: revenue from operations Rs 7.78 lakh (up from Rs 7.16 lakh YoY), total income Rs 9.04 lakh, net profit Rs 0.65 lakh (down from Rs 1.28 lakh). Mr. Swaraj Kumar Singh resigned as Whole-Time Director and CFO due to pre-occupancy. Ms. Roshni Poddar appointed as new Whole-Time Director and CFO for 5 years. 30th AGM set for September 23, 2026 via video conference.
Likely market impact
CFO changeover appears planned. Q1 net profit fell about 49% year-on-year, which may concern investors.